Zevra Therapeutics Reports Q2 2026 Financial Results

What Happened
Zevra Therapeutics, Inc. (ZVRA) filed a Form 8‑K on August 5, 2026 announcing its financial results and corporate updates for the quarter ended June 30, 2026. The company issued a press release and scheduled a conference call and audio webcast for Wednesday, August 5, 2026 at 4:30 p.m. ET to discuss the results and updates.

Key Details

• Press release announcing Q2 2026 results furnished as Exhibit 99.1 to the Form 8‑K (dated August 5, 2026).
• The quarter covered is the three months ended June 30, 2026.
• Management hosted a conference call and audio webcast on Aug 5, 2026 at 4:30 p.m. ET to review results and corporate updates.
• The press release is furnished (not “filed”) for purposes of Section 18 of the Securities Exchange Act and is not incorporated by reference into other filings unless explicitly stated.

Why It Matters
This filing signals that Zevra has released its latest quarterly results and will provide management commentary via a call and webcast—events investors commonly use to assess recent performance, guidance, and strategic updates. Retail investors should review the press release and consider listening to the webcast for details on revenue, expenses, cash position, or operational milestones disclosed there. The company’s note that the release is “furnished” (not “filed”) is a legal technicality regarding incorporation by reference in future SEC filings.